Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

Hummel TR, Chow LM, Fouladi M, Franz D.

Paediatr Drugs. 2013 Feb;15(1):29-42. doi: 10.1007/s40272-012-0002-4. Review.

PMID:
23329387
2.

Small molecule inhibitors in children with malignant gliomas.

Herrington B, Kieran MW.

Pediatr Blood Cancer. 2009 Sep;53(3):312-7. doi: 10.1002/pbc.21950. Review.

PMID:
19434732
4.

Treatment of high-grade glioma in children and adolescents.

MacDonald TJ, Aguilera D, Kramm CM.

Neuro Oncol. 2011 Oct;13(10):1049-58. doi: 10.1093/neuonc/nor092. Epub 2011 Jul 22. Review.

5.

Antiangiogenic therapy for high-grade gliomas.

Chamberlain MC, Raizer J.

CNS Neurol Disord Drug Targets. 2009 Jun;8(3):184-94. Review.

PMID:
19601816
6.

An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.

Kyritsis AP, Levin VA.

Cancer Chemother Pharmacol. 2011 May;67(5):971-83. doi: 10.1007/s00280-011-1617-9. Epub 2011 Mar 27. Review.

PMID:
21442438
7.

The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas.

Dasgupta T, Haas-Kogan DA.

Front Oncol. 2013 May 10;3:110. doi: 10.3389/fonc.2013.00110. eCollection 2013.

8.

Thalamic high-grade gliomas in children: a distinct clinical subset?

Kramm CM, Butenhoff S, Rausche U, Warmuth-Metz M, Kortmann RD, Pietsch T, Gnekow A, Jorch N, Janssen G, Berthold F, Wolff JE.

Neuro Oncol. 2011 Jun;13(6):680-9. doi: 10.1093/neuonc/nor045.

9.

New chemotherapy options for the treatment of malignant gliomas.

Soffietti R, Rudà R, Trevisan E.

Anticancer Drugs. 2007 Jul;18(6):621-32. Review.

PMID:
17762390
10.

Adjuvant chemotherapy in the treatment of high grade gliomas.

Lonardi S, Tosoni A, Brandes AA.

Cancer Treat Rev. 2005 Apr;31(2):79-89. Review.

PMID:
15847978
11.

Chemotherapeutic options for primary brain tumors.

Kim L, Glantz M.

Curr Treat Options Oncol. 2006 Nov;7(6):467-78. Review.

PMID:
17032559
12.

Cilengitide in bevacizumab-refractory high-grade glioma: two case reports and critical review of the literature.

Lombardi G, Zustovich F, Farina P, Polo V, Farina M, Puppa AD, Bertorelle R, Gardiman MP, Berti F, Zagonel V.

Anticancer Drugs. 2012 Aug;23(7):749-53. doi: 10.1097/CAD.0b013e3283520e2c. Review.

PMID:
22382388
13.

Targeted molecular therapy of malignant gliomas.

Kesari S, Ramakrishna N, Sauvageot C, Stiles CD, Wen PY.

Curr Neurol Neurosci Rep. 2005 May;5(3):186-97. Review.

PMID:
15865884
15.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

16.

Targeted therapy in pediatric low-grade glioma.

Kilday JP, Bartels UK, Bouffet E.

Curr Neurol Neurosci Rep. 2014 Apr;14(4):441. doi: 10.1007/s11910-014-0441-0. Review.

PMID:
24604059
17.

Chemotherapy in the treatment of malignant gliomas.

Stern JI, Raizer JJ.

Expert Rev Anticancer Ther. 2006 May;6(5):755-67. Review.

PMID:
16759165
18.

Pediatric glial tumors.

Cohen KJ, Broniscer A, Glod J.

Curr Treat Options Oncol. 2001 Dec;2(6):529-36. Review.

PMID:
12057098
19.

Therapy for recurrent malignant glioma in adults.

Mrugala MM, Kesari S, Ramakrishna N, Wen PY.

Expert Rev Anticancer Ther. 2004 Oct;4(5):759-82. Review.

PMID:
15485312
Items per page

Supplemental Content

Write to the Help Desk